The Cost-Effectiveness of Bendamustine Versus Fludarabine for the First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Mexico
Abstract
Authors
D. Bertwistle J. Munakata E. Wehler V. Leyva A. Valencia A. Hernandez L. de la Torre L. Gonzalez